Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
J
Jenburkt Pharmaceuticals Ltd
Score 68/100• Decent
Jenburkt Pharmaceuticals Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised.
Company’s Health84/100
Valuation 40/100 · PB 3.2705
Technical Watch
1M 4.281% 6M 23.817% 1Y 32.539%
Confidence100%
Low leverage (D/E)No promoter pledge
#46
View details ➜
T
Trident Lifeline Ltd
Score 68/100• Decent
Trident Lifeline Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised.
Company’s Health70/100
Valuation 40/100 · PB 4.9931
Technical Avoid
1M 10.04% 6M -0.332% 1Y -3.846%
Confidence100%
Healthy profit marginsDecent revenue growth
Promoter pledge present
#47
View details ➜
T
Themis Medicare Ltd
Score 68/100• Decent
Themis Medicare Ltd shows potential but faces several challenges that could impact future performance.
Company’s Health73/100
Valuation 60/100 · PB 2.8398
Technical Avoid
1M -7.432% 6M -3.006% 1Y -52.57%
Confidence100%
Low leverage (D/E)Reasonable PB valuation
Weak ROEPromoter pledge present
#48
View details ➜
T
Tatva Chintan Pharma Chem Ltd
Score 68/100• Decent
Tatva Chintan Pharma Chem Ltd shows potential for growth in a favorable sector, but valuation concerns and execution risks should be monitored.
Company’s Health72/100
Valuation 40/100 · PB 4.5032
Technical Momentum
1M 34.341% 6M 102.146% 1Y 67.774%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#49
View details ➜
S
Suven Life Sciences Ltd
Score 68/100• Decent
Suven Life Sciences Ltd shows potential for growth, but faces challenges in valuation and execution risks.
Company’s Health49/100
Valuation 20/100 · PB 40.856
Technical Avoid
1M -5.734% 6M 61.016% 1Y 57.247%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#50
View details ➜
S
Solara Active Pharma Sciences Ltd
Score 68/100• Decent
Solara Active Pharma Sciences Ltd shows potential for growth, but faces challenges in profitability and market competition.
Company’s Health24/100
Valuation 60/100 · PB 2.436
Technical Avoid
1M -0.025% 6M 21.307% 1Y -22.581%
Confidence100%
Reasonable PB valuation
Weak ROEPromoter pledge present
#51
View details ➜
S
SMS Pharmaceuticals Ltd
Score 68/100• Decent
SMS Pharmaceuticals Ltd shows decent potential with consistent growth, but faces challenges in valuation and liquidity.
Company’s Health66/100
Valuation 40/100 · PB 4.1828
Technical Momentum
1M 16.863% 6M 19.361% 1Y -2.975%
Confidence100%
Low leverage (D/E)
Weak ROEPromoter pledge present
#52
View details ➜
S
Shukra Pharmaceuticals Ltd
Score 68/100• Decent
Shukra Pharmaceuticals Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised for investors.
Company’s Health89/100
Valuation 20/100 · PB 28.5764
Technical Momentum
1M 19.033% 6M 169.803% 1Y 480.467%
Confidence100%
Low leverage (D/E)No promoter pledge
#53
View details ➜
S
Shelter Pharma Ltd
Score 68/100• Decent
Shelter Pharma Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised.
Company’s Health84/100
Valuation 80/100 · PB 1.4518
Technical Avoid
1M -3.552% 6M 8.39% 1Y -29.688%
Confidence100%
Low leverage (D/E)No promoter pledge
#54
View details ➜
S
Shanmuga Hospital Ltd
Score 68/100• Decent
Shanmuga Hospital Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised.
Company’s Health93/100
Valuation 80/100 · PB 1.4491
Technical Avoid
1M -3.403% 6M 18.608% 1Y -17.622%
Confidence100%
Low leverage (D/E)No promoter pledge
#55
View details ➜
S
Shalby Ltd
Score 68/100• Decent
Shalby Ltd shows potential in a growing sector, but faces challenges in growth consistency and valuation. Caution is advised.
Company’s Health75/100
Valuation 60/100 · PB 2.6012
Technical Avoid
1M -8.881% 6M 28.549% 1Y 2.159%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#56
View details ➜
S
Samrat Pharmachem Ltd
Score 68/100• Decent
Samrat Pharmachem Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
Company’s Health75/100
Valuation 80/100 · PB 1.2516
Technical Avoid
1M -2.475% 6M -18.938% 1Y -38.948%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#57
View details ➜
R
Rainbow Children's Medicare Ltd
Score 68/100• Decent
Rainbow Children's Medicare Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health92/100
Valuation 20/100 · PB 9.4288
Technical Avoid
1M 2.556% 6M 0.676% 1Y -15.165%
Confidence100%
No promoter pledgeHealthy profit margins
#58
View details ➜
P
Panacea Biotec Ltd
Score 68/100• Decent
Panacea Biotec Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health55/100
Valuation 40/100 · PB 3.2014
Technical Avoid
1M 8.064% 6M -19.592% 1Y 32.116%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#59
View details ➜
M
Mankind Pharma Ltd
Score 68/100• Decent
Mankind Pharma Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
Company’s Health97/100
Valuation 20/100 · PB 6.7546
Technical Avoid
1M 0.613% 6M -0.075% 1Y -10.623%
Confidence100%
No promoter pledgeHealthy profit margins
#60
View details ➜
Showing 46 to 60 of 301 (21 Pages)